1Vincent RG, Chu - TM, Lane - WW. The value of CEA in patients with carcinoma of the lung. Cancer. 1979,44:685.
2Brochot JM, Chevret S, Natal J, et al. Diagnostic and prognostic value of CYFRA21 - 1 compared with other tumor markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Zur J Cancer. 1997,33 ( 3 ) :385.
3Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics[J].Cancer J Clin,2005,55(2):74-108.
4Matsuoka K,Sumitomo S,Nakashima N,et al.Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stageⅠnon-small cell lung cancer[J].Eur J Cardiothorac Surg,2007,32(3):435-439.
5Fabrice Barlesi,Celine Gimenez,Jean-Philippe Torre,et al.Prognostic value of combination of CYFRA21-1,CEA and NSE in patients with advanced non-small cell lung cancer[J].Respir Med,2004,98:357-362.
6Bonner JA,Sloan JA,Rowl KM,et al.Significance of neuron specific enolase levels before and during therapy for small cell lung cancer[J].Clin Cancer Res,2000,6(2):597-601.
7Monika Zaleska,Monika Szturmowicz,Jacek Zych,et al.Elevated serum NSE in inoperable non-small-cell lung carcinoma(NSCLC) is associated with a better response but worse prognosis[J].Pneui Alerg Polska,2010,78(1):14-20.
8Roy MB,Stein S,Ulf A,et al.The value of prognostic factors in small cell lung cancer:results from a randomised multicenter study with minimum 5 year follow-up[J].Lung Cancer,2003,39:303-313.
9Ando S,Kimura H,Iwai N,et al.Optimal combination of seven tumor markers in prediction of advanced stage at first examination of patients with non-small lung cancer[J].Anticancer Res,2001,21(4B):3085-3092.
10Muley T,Dienemann H,Ebert W,et al.CYFRA21-1 and CEA are independent prognostic factors in 153 operated stageⅠNSCLC patients[J].Anticancer Res,2004,24(3B):1953-1956.
2MOLINA R, FILELLA X, AUG J M, et al. Tumour markers (CEA, CA 125, CYFRA 21 -l, SCC and NSE) in patients with non - small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors [ J]. Tumour Biol, 2003, 24 (4) : 209 - 218.
3KULPA J, WOJCIK E, REINFUSS M, et al. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21 - 1, and neuron - specific enolase in squamous cell lung cancer patients [J]. ClinChem, 2002, 48(11): 1931-1937.
4ARDIZZONI A, CAFFERATA M A, TISEO M, et al. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer [J]. Cancer, 2006, 107 (12) : 2842 -2849.
5OKADA M, N|SHIO W, SAKAMOTO T, et al. Prognostic signifi- cance of perioperative serum carcinoembryonic antigen in non - small cell lung cancer: analysis of 1, 000 consecutive resections for clinical stage I disease [ J ]. Ann Thorac Surg, 2004, 78 ( 1 ) : 216 -221.
6CEDRES S, NUNEZ I, LONGO M, et al. Serum tumor markers CEA, CYFRA21 - 1, and CA - 125 are associated with worse prognosis in advanced non - small - cell lung cancer ( NSCLC ) [J]. Clin Lung Cancer, 2011, 12(3): 172 -179.
7MOLINA R, AUGE J M, BOSCH X, et al. Usefulness of serum tumor markers, including progastrin - releasing peptide, in pa- tients with lung cancer: correlation with histology[J]. Tumour Biol, 2009, 30(3): 121 -129.
8Cedres S,Nunez I,Longo M,et al.Serum tumor markers CEA,CYFRA21-1,and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer(NSCLC)[J].Clin Lung Cancer,2011,12(3):172-179.
9Molina R,Auge JM,Bosch X,et al.Usefulness of serum tumor markers,including progastrin-releasing peptide,in patients with lung cancer:correlation with histology[J].Tumour Biol,2009,30(3):121-129.
10MOLINA R, FILELLA X, AUGI J M, et al. Tumour markers (CEA,CA 125,CYFRA 21 -1 ,SCC and NSE) in patients with non- small cell lung cancer as an aid in histological diagnosis andprognosis. Comparison with the main clinical and pathological prognostic factors[J] . Tumour Biol, 2003, 24(4) : 209-218.
